Differences in Pathological Characteristics and Prognosis of Clinical A2 Prostatic Cancer from A1 and B Disease-Reference-Cited by-同舟云学术

Differences in Pathological Characteristics and Prognosis of Clinical A2 Prostatic Cancer from A1 and B Disease

Published:1978-05 Issue:5 Volume:119 Page:618-622
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Golimbu Mircea¹,Schinella Roger¹,Morales Pablo¹,Kurusu Shozo¹

Affiliation:

1. From the Departments of Urology and Pathology, New York University Medical Center and New York Veterans Administration Hospital, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference37 articles.

1. Symposium on hormones and cancer therapy; hormone therapy in prostatic cancer;Whitmore;Amer. J. Med.,1956

2. Unsuspected carcinoma of the prostate in suprapubic prostatectomy specimens; a clinicopathological study of 55 consecutive cases;Bauer;Cancer,1960

3. The natural history of prostatic cancer;Whitmore;Cancer,1973

4. The present status of radical prostatectomy for stages A and B prostatic cancer;Jewett;Urol. Clin. N. Amer.,1975

5. Kerr, W.S.: Comment made at annual meeting, American Urological Association, Las Vegas, Nevada, May 16–20, 1976.

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radical prostatectomy findings in patients with locally aggressive Grade group 5 prostatic adenocarcinoma and negative limited or extended pelvic lymph node dissection;Pathology - Research and Practice;2023-04

2. Contemporary management of patients with T1a and T1b prostate cancer;Current Opinion in Urology;2011-05

3. When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy?;International Journal of Urology;2010-12-30

4. Outcome of radical prostatectomy for incidental carcinoma of the prostate;BJU International;2009-06

5. Radical Prostatectomy for Incidental (Stage T1a–T1b) Prostate Cancer: Analysis of Predictors for Residual Disease and Biochemical Recurrence;European Urology;2008-07